2m 2m 2m 2m 2m 2m 2m
NEUROGENE (NGNE)
NASDAQ
$38.62-$0.02 (-0.04%)
Price as of Aug 21, 2026 7:30 PM EDT- $773.0MMarket Cap
- 93.25%1-Year Change
- BiotechnologyIndustry
NEUROGENE (NGNE)
$38.62-$0.02 (-0.04%)
NGNE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.63 | ||
Change | +$0.64 (+1.68%) | ||
Open | $38.41 | ||
High | $39.44 | ||
Low | $37.53 | ||
Previous Close | $37.99 | ||
Volume | 346,580 | ||
30-Day Average Volume | 178,133 | ||
1-Week Change | 6.89% | ||
1-Month Change | 5.32% | ||
1-Year Change | 93.25% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 20.0M | ||
Total Assets | $244.4M | ||
Market Cap | $773.0M | ||
Enterprise Value | $660.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$34.5M | ||
EBITDA | -$33.7M | ||
Net Working Capital | $207.4M | ||
EPS | -$1.53 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -25 | ||
PEG | 3 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 09/25/2023 | ||
Earnings & Revenue